Clinical trials recruiting for Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ALN-HSD | 1 |
| Incretin-Based Therapy | 1 |
| Survodutide | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 3 |
| Indiana | 3 |
| California | 2 |
| Colorado | 2 |
| Florida | 2 |
| Louisiana | 2 |
| Maryland | 2 |
| Minnesota | 2 |
| Mississippi | 2 |
| Missouri | 2 |
| New York | 2 |
| Ohio | 2 |
Top cities
Self-screener
Recruiting trials
- A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Fibrosis Lessens After Metabolic Surgery
- LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Related conditions
Trials recruiting for Metabolic Dysfunction-Associated Steatohepatitis (MASH) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metabolic Dysfunction-Associated Steatohepatitis (MASH) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.